References |
Top |
REF 1 |
Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4.
|
REF 2 |
Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling. Cancer Res. 2007 Feb 1;67(3):911-8.
|
REF 3 |
Dazap2 modulates transcription driven by the Wnt effector TCF-4. Nucleic Acids Res. 2009 May;37(9):3007-20.
|
REF 4 |
-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Gastroenterology. 2012 Mar;142(3):572-81.
|
REF 5 |
MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem. 2009 Jul 17;284(29):19613-22.
|
REF 6 |
Physiological and functional interactions between Tcf4 and Daxx in colon cancer cells. J Biol Chem. 2006 Jun 2;281(22):15405-11.
|
REF 7 |
Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells. Mol Cancer Res. 2006 Oct;4(10):729-45.
|
REF 8 |
The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated -catenin by sequestering TCF4 to the nuclear membrane. Sci Signal. 2015 Sep 8;8(393):ra90.
|
REF 9 |
XIAP monoubiquitylates Groucho/TLE to promote canonical Wnt signaling. Mol Cell. 2012 Mar 9;45(5):619-28.
|
REF 10 |
HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr Relat Cancer. 2007 Sep;14(3):655-67.
|
REF 11 |
Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell. 2006 Apr 21;125(2):327-41.
|
REF 12 |
Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential. Biochem Biophys Res Commun. 2009 Sep 4;386(4):762-8.
|